As a new-type foreign trade service provider driven by both technology transformation and foreign trade business, HiSiaddi has established a "1+2+3+4=1" service system and can supply original factory sources of Tris(dibenzylideneacetone)dipalladium chloroform adduct from multiple well-known brands. Boasting over a decade of market experience and technological transformation cooperation with manufacturers, HiSiaddi possesses extensive expertise in product compliance issues. Below is a case of HiSiaddi resolving compliance issues for Tris(dibenzylideneacetone)dipalladium chloroform adduct.
For further inquiries regarding compliance matters for Tris(dibenzylideneacetone)dipalladium chloroform adduct, please contact HiSiaddi customer service.
BioChem GmbH, a Munich-based German high-end custom API CDMO pharmaceutical enterprise, specializes in commercial production of targeted small-molecule new drugs. Tris(dibenzylideneacetone)dipalladium chloroform adduct (CAS: 52522-40-4) functions as the core zero-valent palladium catalyst for its Suzuki and Buchwald-Hartwig coupling reactions, with stable annual procurement of 85 kg pharmacopoeia-grade material and long-term sourcing from original Johnson Matthey European factories.
Amid surging European precious metal prices and extended overseas manufacturer lead times of up to 75 days, the client initiated localized procurement and finalized mass production supply from a leading domestic manufacturer. Four major cross-border compliance issues subsequently emerged, halting finished goods pending domestic shipment, with German customs forecasting detention upon port arrival. As an EU pharmaceutical regulatory registration enterprise, raw material compliance directly impacts CEP filing for its pipeline new drugs; non-compliant raw materials risk full suspension of the API production line. The client urgently entrusted HiSiaddi with full oversight of end-to-end compliance rectification and export customs clearance.
The domestic production manufacturer contacted by the client only provided Chinese national standard SDS and lacked familiarity with EU REACH, CLP, German WGK aquatic environmental regulations, dangerous goods export and API registration supporting documentation. Manufacturers solely focused on production with no supporting foreign trade compliance capabilities, leaving all compliance gaps to be fully resolved by HiSiaddi.
Manufacturers supplied SDS drafted per Chinese national standard GB/T16483, not the 16-chapter English compliant SDS mandated under EU Regulation 2020/878. Product GHS labels only contained Chinese text, omitting EU-mandated pictograms GHS07, GHS08, hazard statements H302/H315/H351 and precautionary P-statements. German customs strictly verify compliant SDS and CLP labels, rejecting shipments with non-conforming documentation. Containing crystalline chloroform, the product falls under WGK3 high aquatic hazard classification requiring supplementary German local aquatic environmental control declarations, which manufacturers could not provide.
Manufacturers self-reported an erroneous HS code classification under general precious metal salts 28439000. This catalyst qualifies as a fine organic coordination catalyst, with the compliant tariff code 3815120090 (precious metal active substance catalysts). Misclassification triggers abnormal export tax rebates, miscalculated German import tariffs and customs inspection detention. Missing standardized declaration elements (CAS number, palladium content, catalytic application, model) and notarized English versions of third-party full-test COA.
Per GHS classification, the product is categorized as Acute Toxicity Category 4, Skin Corrosion/Irritation Category 2 and Suspected Carcinogen Category 2, qualifying as a restricted hazardous chemical. Manufacturers used simple generic PE plastic drum packaging without Inspection and Quarantine Bureau-issued Exit Dangerous Goods Packaging Performance Certificates, resulting in ocean freight forwarders refusing booking space and inability to arrange ocean container shipments. Incomplete domestic commodity inspection declaration documentation prevented acquisition of exit inspection and quarantine certification.
As an EU CDMO pharmaceutical enterprise, the client’s API CEP pharmacopoeia filing requires accompanying documentation: catalyst palladium impurity control descriptions, full traceability test reports for free DBA and residual chloroform, raw material source certificates, and SVHC Substance of Very High Concern screening reports. Chloroform contained within the product falls under SVHC control requiring additional reporting if content exceeds limits. Domestic manufacturers lacked registration-grade supporting technical documentation, blocking the client’s new drug registration filing process.
1. Partnering with a third-party compliance laboratory, HiSiaddi redrafted full 16-chapter English SDS aligned with REACH Annex II and CLP Regulation 1272/2008, completing comprehensive coverage of product composition, toxicological data, aquatic environmental hazards, storage & transportation specifications and waste disposal, with measured SVHC chloroform content clearly annotated.
2. Issue German-language aquatic environmental compliance declarations aligned with German WGK3 control standards to satisfy local German environmental access requirements.
3. Replace all outer packaging labels with EU-standard printed warning pictograms, complete H/P hazard clauses, English product name, CAS number and dual filing information of the manufacturer and HiSiaddi foreign trade entity. All labels are supplied in physical and digital archive formats to meet German customs inspection requirements.
1. HiSiaddi assisted with accurate reclassification under tariff code 3815120090 for precious metal catalysts, compiling complete standardized declaration elements including CAS 52522-40-4, 20.35% palladium content, application for pharmaceutical intermediate coupling catalysis, brand model and SVHC testing results.
2. Coordinate authoritative third-party testing institutions to issue bilingual notarized COA detailing full test data for palladium content, free DBA, chloroform residues and heavy metal impurities, serving as shared documentation for customs declaration and client pharmaceutical regulatory registration.
3. Organize domestic export customs declaration forms, foreign trade contracts, packing lists and certificates of origin with unified documentary logic to eliminate declaration inconsistency risks.
1. Guide manufacturers to switch to compliant packaging: inner vacuum-sealed aluminum foil packaging paired with outer UN-certified hazardous material fiber drums to prevent product oxidation from moisture and chloroform volatile leakage.
2. Collaborate with packaging manufacturers to submit packaging samples to local Inspection and Quarantine Bureaus for testing, acquiring Exit Dangerous Goods Packaging Performance Inspection Result Certificates and completing product exit inspection & quarantine to obtain release slips for smooth ocean freight booking with forwarders.
3. Compile ocean dangerous goods declaration documentation simultaneously to complete carrier DG hazardous goods filings and resolve shipment booking denials.
1. Collaborate with manufacturer laboratories to issue catalyst impurity control scheme reports detailing process control for palladium residues, free ligand and chloroform residues during synthesis, aligned with ICH Q3D heavy metal impurity control standards to support the client’s API palladium removal process filing.
2. Commission EU-recognized third-party laboratories to issue SVHC screening reports confirming measured chloroform content within compliant limits, exempting mandatory REACH substance registration notifications.
3. Organize raw material traceability documentation (palladium source procurement vouchers, batch production quality control records) bound into pharmaceutical registration dossiers for direct filing with German pharmaceutical regulatory authorities for CEP applications.
1. First compliant shipment: Following completion of full compliance documentation rectification, the initial 30 kg was split into two batches for inspection, customs clearance and ocean freight to Hamburg Port. German customs verified all compliant documentation for smooth customs clearance and warehouse entry. Small-batch laboratory feeding tests conducted by the client yielded catalytic indicators matching original Johnson Matthey products.
2. Execution of annual framework procurement contract: The remaining 55 kg was shipped in four monthly batches, fully delivering the annual 85 kg procurement framework agreement. Comprehensive localized procurement costs decreased by 29.7% relative to original imported equivalents.
3. Long-term compliance custodianship cooperation: For subsequent procurement of two additional modified palladium catalyst grades newly developed by the client, full-process export compliance custodianship was fully entrusted to HiSiaddi. The German pharmaceutical enterprise also referred two Dutch and Austrian European high-end new drug enterprises to source samples of the identical catalyst product.
1. Industry Pain Point: Domestic palladium catalyst manufacturers focus exclusively on product synthesis and production, universally lacking expertise in EU chemical regulations, hazardous goods export and overseas pharmaceutical registration compliance, only capable of supplying standard domestic documentation. Overseas mid-to-high-end pharmaceutical clients are bound by multi-layered EU pharmaceutical regulatory, customs and environmental laws, where raw material compliance is directly tied to new drug registration and mass production. Severe compliance information disconnection between supply and demand sides readily triggers cargo detention, return shipments and full production line shutdown losses.
2. Core Value of HiSiaddi: Combining dual expertise in precious metal catalyst product knowledge and cross-border chemical compliance, we deliver a closed-loop full compliance service covering regulatory documentation rectification → packaging & commodity inspection → customs classification → overseas pharmaceutical registration dossier preparation. We resolve multi-dimensional compliance challenges for clients as a one-stop service, building long-term trust with European high-end pharmaceutical enterprises through compliance services and securing sustained repeat order business.
For further inquiries regarding compliance matters for Tris(dibenzylideneacetone)dipalladium chloroform adduct, please contact HiSiaddi customer service.
+86-13120989737 
info@hisiaddi.com 
English
